Iovance stock sank after phase 2 Amtagvi lung cancer data. Read more here. Rasi Bhadramani/iStock via Getty Images - Iovance Biotherapeutics (IOVA) is down ~34% in Thursday trading after releasing data for two cohorts of a phase 2 trial of Amtagvi (lifileucel) for…
From taladegib to admilparant and inhaled treprostinil, here are the key 2026 advances in idiopathic pulmonary fibrosis care. Researchers and pharmaceutical companies made major strides in idiopathic pulmonary fibrosis (IPF) care this year with a host of investigational clinical trials, new…
Novavax (NVAX) has earned a $125 million milestone payment related to Sanofi's (SNY) initiation of a phase 3 influenza-COVID-19 combination vaccine trial in Europe using Novavax's Nuvaxovid COVID-19... Oops, something went wrong U.S. markets close in 2h 49m Novavax Earns $125 Million Milestone Payment From Sanofi's…
An experimental drug that Genmab gained in an $8 billion buyout succeeded in a late-stage trial in a form of head and neck cancer, sending shares of the Danish drugmaker soaring to an all-time high. At an early analysis, a combination…
Drug makers can face legal liability when they fail to adequately warn consumers about known or foreseeable risks of their products. Pharmaceutical products can pose health risks for several reasons. Some medications contain active ingredients that can harm you if…
SAN FRANCISCO, October 29, 2026--Edison Scientific announces agreement with Pfizer to accelerate research and development Oops, something went wrong U.S. markets close in 4h 53m Edison Scientific Announces Agreement with Pfizer to Accelerate Research and Development SAN FRANCISCO, October 29, 2026--(BUSINESS WIRE)--Edison Scientific announced…
The story is only half the picture See behind the headlines See the data moving US, ASX and crypto markets right now. AbbVie (NYSE:ABBV) reported a 40.5% endoscopic remission rate at Week 24 for investigational ABBV-466 in its 300-patient Phase 2a TARGET-CD…
The FDA approved GSK's bepirovirsen for adults with chronic hepatitis B on nucleoside therapy, based on phase 3 trials showing 19% functional cure. The FDA has approved Hibsago (bepirovirsen), GSK’s antisense oligonucleotide, for adults with chronic hepatitis B who are already taking…
Novavax (Nasdaq: NVAX) has earned a $125 million milestone payment with the initiation (fifth patient dosed) of Sanofi's Phase 3 influenza-COVID-19 combination vaccine trial utilizing Novavax's COVID-19 vaccine, Nuvaxovid™. Sanofi's Phase 3 trial, being conducted in Europe, is assessing the safety and immunogenicity…
Randomized, placebo-controlled study to evaluate the safety, tolerability, and efficacy in a robust, two-part study First-in-class therapeutic targets Alveolar Epithelial Type 2 (AEC2) cells with the aim to halt disease progression and promote repair of fibrotic damage in IPF The ORBIT-IPF is…
Eli Lilly, Novo Nordisk, Pfizer, Merck, AstraZeneca, Roche, Novartis and other drug giants as biotech players: their pipelines, deals and research.
An article joins this feed when it matches these terms. Each one is also a search of its own.